Post

New research · Ophthalmology
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 16h
StudyCanadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026

Intravitreal fluocinolone acetonide 0.19 mg Iluvien implant for radiation maculopathy.

Paul T Finger, Shayri Pillai, Ankit Singh Tomar
Read paper
OphthalmologyStudy

Central foveal thickness decreased 6 months after fluocinolone implant for radiation maculopathy

Intravitreal fluocinolone acetonide 0.19 mg Iluvien implant for radiation maculopathy.

Paul T Finger … Ankit Singh Tomar
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026
Purpose

To evaluate the efficacy of a long-acting fluocinolone acetonide 0.19 mg Iluvien intravitreal (FAc) implant for the treatment of radiation maculopathy (radiation maculopathy).

Methods

Seven patients treated for uveal melanoma with palladium-103 plaque brachytherapy who developed radiation maculopathy.

Results

swelling in the retina's center eased, a sign of improved vision

Baseline CFT
390μm
6 months
300μm
Last follow-up
383μm
More results

The median radiation dose to the fovea was 45.9 Gy (mean: 61.8, range: 6.4-135.6).

Radiation maculopathy onset occurred at a median of 12 months post-radiation.

Patients received anti-VEGF therapy for 71 months (mean) before FAc implantation.

More results

A median of 1 (mean: 2, range: 1-3) FAc implant was placed per patient, beginning in 2018.

“
Conclusion · 1 of 2

FAc implants were an effective treatment for radiation maculopathy patients who were refractory or intolerant to maximal intravitreal anti-VEGF therapy.

Conclusion · 2 of 2

They achieved positive results in the stabilization of macular edema and visual acuity, as well as reduced the intravitreal anti-VEGF injection burden for some patients.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment